These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6091224)

  • 1. [Immunity related to cytomegalovirus after allogenic bone marrow transplantation: role of donor immunity to cytomegalovirus in the incidence of cytomegalovirus infection in recipients].
    Rabian-Herzog C; Varrin F; Gluckmann E; Bertrand C; Harzic M; Ferchal F
    Rev Fr Transfus Immunohematol; 1984 Jun; 27(3):331-6. PubMed ID: 6091224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical aspects of cytomegalovirus infection after allogenic bone marrow grafts].
    Gluckman E; Vilmer E; Devergie A; Mazeron MC; Pérol Y
    Rev Fr Transfus Immunohematol; 1984 Jun; 27(3):337-44. PubMed ID: 6091225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant.
    Meyers JD; Flournoy N; Thomas ED
    J Infect Dis; 1980 Dec; 142(6):816-24. PubMed ID: 6257800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus (CMV) in the compromised host(s).
    Betts RF; Hanshaw JB
    Annu Rev Med; 1977; 28():103-10. PubMed ID: 193429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of pre bone marrow transplantation serology in determining subsequent cytomegalovirus infection. An analysis of risk factors.
    Paulin T; Ringdén O; Lönnqvist B; Wahren B; Nilsson B
    Scand J Infect Dis; 1986; 18(3):199-209. PubMed ID: 3016884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different kinetics in anti-cytomegalovirus immunity reconstitution evaluated by lymphocyte proliferation and IFN-gamma production in allogeneic and autologous bone marrow transplantation.
    Mendes AV; Benard G; Pereira CB; Kallas EG; Duarte AJ; Pannuti CS; Dulley FL; Machado CM
    Acta Haematol; 2002; 107(4):187-94. PubMed ID: 12053145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation.
    Boland GJ; Vlieger AM; Ververs C; De Gast GC
    Clin Exp Immunol; 1992 Jun; 88(3):506-11. PubMed ID: 1318805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG-subclass-specific CMV reactivity in bone marrow transplant recipients.
    Wahren B; Linde A; Sundqvist VA; Ljungman P; Lönnqvist B; Ringdén O
    Transplantation; 1984 Nov; 38(5):479-83. PubMed ID: 6093297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CMV infections in bone marrow transplanted patients--evaluation of prophylaxis with Cytotect (CMV hyperimmuneglobulin).
    Zintl F; Färber I; Hermann J; Fuchs D; Prager J; Wutzler P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):557-64. PubMed ID: 2480308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
    Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
    Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus-specific lymphocyte proliferation and in vitro cytomegalovirus IgG synthesis for diagnosis of cytomegalovirus infections after bone marrow transplantation.
    Ljungman P; Lönnqvist B; Gahrton G; Ringdén O; Wahren B
    Blood; 1986 Jul; 68(1):108-12. PubMed ID: 3013339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation.
    Einsele H; Ehninger G; Steidle M; Fischer I; Bihler S; Gerneth F; Vallbracht A; Schmidt H; Waller HD; Müller CA
    Blood; 1993 Sep; 82(5):1672-8. PubMed ID: 8395913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus (CMV) excretion as a factor in the severity of CMV disease in kidney and simultaneous kidney and pancreas transplantation.
    Pouteil-Noble C; Ecochard R; Bosshard S; Lacavalerie B; Donia A; Landrivon G; Tardy JC; Dubernard JM; Aymard M; Touraine JL
    Transpl Int; 1992; 5 Suppl 1():S26-9. PubMed ID: 14621724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.
    Walter EA; Greenberg PD; Gilbert MJ; Finch RJ; Watanabe KS; Thomas ED; Riddell SR
    N Engl J Med; 1995 Oct; 333(16):1038-44. PubMed ID: 7675046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood products.
    Rubie H; Attal M; Campardou AM; Gayet-Mengelle C; Payen C; Sanguignol F; Calot JP; Charlet JP; Robert A; Huguet F
    Bone Marrow Transplant; 1993 Mar; 11(3):209-14. PubMed ID: 8385522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation.
    Verdonck LF; de Graan-Hentzen YC; Dekker AW; Mudde GC; de Gast GC
    Bone Marrow Transplant; 1987 Jun; 2(1):73-8. PubMed ID: 2844337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure.
    Nakamura R; Battiwalla M; Solomon S; Follmann D; Chakrabarti S; Cortez K; Hensel N; Childs R; Barrett AJ
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):49-57. PubMed ID: 14752779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte responses after cytomegalovirus infection in bone marrow transplant recipients--a one-year follow-up.
    Ljungman P; Lönnqvist B; Wahren B; Ringdén O; Gahrton G
    Transplantation; 1985 Nov; 40(5):515-20. PubMed ID: 2997952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus immunity in allogeneic marrow grafting.
    Gratama JW; Middeldorp JM; Sinnige LG; van der Meer JW; D'Amaro J; Jansen J; Zwaan FE; Brand A; de Gast GC; The TH
    Transplantation; 1985 Nov; 40(5):510-4. PubMed ID: 2997951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation from a pediatric donor with a high frequency of cytomegalovirus-specific T-cells.
    Komatsu H; Kogawa K; Nonoyama S; Inui A; Sogo T; Fujisawa T; Klenerman P
    J Med Virol; 2006 Dec; 78(12):1616-23. PubMed ID: 17063516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.